Boswellia Extract 1,000 mg
Single ingredient · 120 servings
Worth trying for Joint health
Probably helps: joint stiffness. In adults with knee osteoarthritis
- Evidence Worth trying
- Dose 1 of 1 at a studied dose
- Safety Read the label's warnings
- Fillers None of concern
What's in it
The dose here lands inside the range studies actually used.
Supplement Facts
Serving Size: 2 Capsule(s)
120 per container
- Boswellia Extract as Boswellic Acids Probably helps · Less joint pain and stiffness › 1,000 mg †
† Daily Value not established
Other ingredients: Cellulose.
Suggested Use: To support joint health we recommend taking 2 capsules (1,000mg) per day with or without food. It is not recommended to exceed 4 capsules per day.
Doses against the trials
-

Boswellia Extract
At the studied dose
1,000 mg a day studies used 100–999 mg · 33 studies
What it's sold for
-
Joint health
Worth trying
Less joint pain and stiffness: probably helps
-
Joint comfort
Worth trying
Less joint pain and stiffness: probably helps
-
Mobility support
Worth trying
Less joint pain and stiffness: probably helps
-
Inflammation support
Worth trying
Less body-wide inflammation: may help
-
Digestive comfort
Worth trying
-
Respiratory comfort
Unproven
Worth knowing
The label's warnings
It is not recommended to exceed 4 capsules per day.
Warning: Consult your physician before use.
Do not use Boswellia if you are pregnant, nursing, or are under 18 years of age.
Do not use Boswellia if you are pregnant, nursing, or are under 18 years of age.
Discontinue use and consult your doctor immediately if any adverse reactions occur. Do not use Boswellia and operate heavy machinery until you know how it affects you.
Medicines its ingredients can clash with
Warfarin, Imipenem, Gentamicin, Other
Reported side effects
Nausea, Headache, Diarrhoea, Vomiting
The other ingredients
Clean formula. The inactive ingredients are standard capsule components.
- Cellulose: bulking agent
Double Wood Supplements
75 out of 100
Brand audit score
Double Wood Supplements presents a transparent, third-party-tested brand posture, but public evidence here is limited to product-level documentation rather than a full company-wide audit.





